{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:35:15Z","timestamp":1790717715350,"version":"4.1.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,15]]},"DOI":"10.18632\/oncotarget.7725","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T02:50:21Z","timestamp":1456455021000},"page":"12089-12101","source":"Crossref","is-referenced-by-count":71,"title":["Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study"],"prefix":"10.18632","volume":"7","author":[{"given":"Guang-hui","family":"Pan","sequence":"first","affiliation":[{"name":"The Transplantation Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[{"name":"The Transplantation Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[{"name":"The Transplantation Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-hui","family":"Zhu","sequence":"additional","affiliation":[{"name":"The Transplantation Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xiang","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Biology and Tissue Engineering, SunYat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-jie","family":"Ma","sequence":"additional","affiliation":[{"name":"The Transplantation Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-wen","family":"Peng","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Biology and Tissue Engineering, SunYat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-hui","family":"Li","sequence":"additional","affiliation":[{"name":"The Transplantation Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yong","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Biology and Tissue Engineering, SunYat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-li","family":"Fang","sequence":"additional","affiliation":[{"name":"The Transplantation Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-he","family":"Guo","sequence":"additional","affiliation":[{"name":"The Transplantation Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Transplantation Centre, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-shan","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Schreiber","year":"1991","journal-title":"Cell"},{"key":"2","first-page":"1000","article-title":"FK 506 for liver, kidney, and pancreas transplantation","volume":"2","author":"Jain","year":"1989","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1592\/phco.24.13.1159.38094","article-title":"Current and future immunosuppressive strategies in renal transplantation","volume":"24","author":"Brennan","year":"2004","journal-title":"Pharmacotherapy"},{"key":"4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology","volume":"78","author":"Allen","year":"2004","journal-title":"Transplantation"},{"key":"5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000319032","article-title":"Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation","volume":"64","author":"Chen","year":"2010","journal-title":"Eur Neurol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1600-6143.2009.02726.x","article-title":"Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation","volume":"9","author":"Halloran","year":"2009","journal-title":"Am J Transplant"},{"key":"7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0301-472X(00)00482-3","article-title":"Mesenchymal stem cells: biology and potential clinical uses","volume":"28","author":"Moseley","year":"2000","journal-title":"Exp Hematol"},{"key":"8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Marshak","year":"1999","journal-title":"Science"},{"key":"9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14653240903193806","article-title":"Mesenchymal stem cells in hematopoietic stem cell transplantation","volume":"11","author":"Hematti","year":"2009","journal-title":"Cytotherapy"},{"key":"10","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft--host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Ringd\u00e9n","year":"2004","journal-title":"Lancet"},{"key":"11","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/bmt.2010.195","article-title":"Mesenchymal stem cell as salvage treatment for refractory chronic GVHD","volume":"45","author":"Xiang","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferationand prolong skin graft survival","volume":"30","author":"Hoffman","year":"2002","journal-title":"Exp Hematol"},{"key":"13","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells","volume":"181","author":"Noris","year":"2008","journal-title":"J Immunol"},{"key":"14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00403-007-0827-9","article-title":"Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model","volume":"300","author":"Bosi","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/TP.0b013e31819b3d72","article-title":"Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients","volume":"87","author":"Hoogduijn","year":"2009","journal-title":"Transplantation"},{"key":"16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"307","author":"Ricordi","year":"2012","journal-title":"JAMA"},{"key":"17","doi-asserted-by":"crossref","first-page":"E158","DOI":"10.1111\/j.1399-0012.2010.01229.x","article-title":"Evaluation of living related kidney donors in China: policies and practices in a transplant center","volume":"24","author":"Zeng","year":"2010","journal-title":"Clin Transplant"},{"key":"18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Crabtree","year":"1992","journal-title":"Immunol Today"},{"key":"19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ni1429","article-title":"T cell-directed therapies: lessons learned and future prospects","volume":"8","author":"O'shea","year":"2007","journal-title":"Nat Immunol"},{"key":"20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.ackd.2005.11.001","article-title":"Calcineurin nephrotoxicity","volume":"13","author":"Haragsim","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"key":"21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/ndt\/16.9.1905","article-title":"Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation","volume":"16","author":"Tett","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0041-1345(98)01633-9","article-title":"Low systemic exposure to tacrolimus correlates with acute rejection","volume":"31","author":"Stevenson","year":"1999","journal-title":"Transplant Proc"},{"key":"23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/TP.0000000000000149","article-title":"Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients","volume":"97","author":"Djamali","year":"2014","journal-title":"Transplantation"},{"key":"24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Karp","year":"2014","journal-title":"Nat Biotechnol"},{"key":"25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trim.2008.08.004","article-title":"Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate","volume":"20","author":"Dahlke","year":"2008","journal-title":"Transpl Immunol"},{"key":"26","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Gianni","year":"2002","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility","volume":"6","author":"Golay","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5966\/sctm.2012-0114","article-title":"Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study","volume":"2","author":"Rabelink","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12967-014-0331-x","article-title":"Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients","volume":"12","author":"de Fijter","year":"2014","journal-title":"J Transl Med"},{"key":"30","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/TP.0b013e31818aa536","article-title":"Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin","volume":"86","author":"Baan","year":"2008","journal-title":"Transplantation"},{"key":"31","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3324\/haematol.2012.067140","article-title":"A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation","volume":"97","author":"Betts","year":"2012","journal-title":"Haematologica"},{"key":"32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbmt.2010.01.011","article-title":"Cotransplantation of mesenchymal stem cells might prevent death from graft--host disease (GVHD) without abrogating graft--tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning","volume":"16","author":"Beguin","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study","volume":"22","author":"Lou","year":"2008","journal-title":"Leukemia"},{"key":"34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrclinonc.2014.102","article-title":"Current and emerging strategies for the prevention of graft--host disease","volume":"11","author":"Reddy","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"35","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.transproceed.2010.03.079","article-title":"Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation","volume":"42","author":"Alessiani","year":"2010","journal-title":"Transplant Proc"},{"key":"36","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2007010044","article-title":"Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes","volume":"18","author":"Floege","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2559.2009.03466.x","article-title":"Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells","volume":"56","author":"Guettier","year":"2010","journal-title":"Histopathology"},{"key":"38","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans","volume":"120","author":"Seyfert-Margolis","year":"2010","journal-title":"J Clin Invest"},{"key":"39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2010.162","article-title":"Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype","volume":"78","author":"Cesbron-Gautier","year":"2010","journal-title":"Kidney Int"},{"key":"40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","article-title":"Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study","volume":"95","author":"Pan","year":"2013","journal-title":"Transplantation"},{"key":"41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.TP.0000157343.27949.9F","article-title":"A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines","volume":"79","author":"Delmonico","year":"2005","journal-title":"Transplantation"},{"key":"42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-007-9661-9","article-title":"Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells","volume":"310","author":"Xiang","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-007-9497-3","article-title":"Proteomic identification of differently expressed proteins responsible for osteoblast differentiation from human mesenchymal stem cells","volume":"304","author":"Xiang","year":"2007","journal-title":"Mol Cell Biochem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:36:48Z","timestamp":1589222208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,25]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,3,15]]}},"alternative-id":["7725","26933811"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7725","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,25]]}}}